Consultation on the Adaptation of the Cochrane Evidence Pipeline beyond Cochrane

2024 Prague [Global Evidence Summit]

Noel-Storr A¹, Dooley G², van Valkenhoef G¹, Wisniewski S¹, Anstee D²

¹Cochrane, London, United Kingdom

²Metaxis, Oxford, United Kingdom